Trinity Biotech's Trinovium unit signs cooling deal with Red Team Investments

Trinity Biotech plc (Nasdaq: TRIB) said on September 9, 2026 that its Trinovium subsidiary, described as a dedicated business unit focused on advanced liquid cooling solutions and fluid intelligence systems for next-generation AI data centers¹, signed a contract with Red Team Investments (RTI), the Texas based owner of the X-MDC, an emerging modular data center technology¹.

The agreement sets up a framework for Trinovium and RTI to develop and deploy direct-to-chip liquid cooling solutions for artificial intelligence, high-performance computing and modular data center applications¹. Under the deal, RTI has committed to serve as a commercial pilot customer, purchasing Trinovium's cooling fluids and analytical systems as part of the pilot deployment¹.

Trinity Biotech said the agreement is expected to provide Trinovium with real-world operating data and customer feedback to support product validation, refinement and broader commercialization¹. The two companies plan to start with integration planning, product testing and pilot deployment, then move to gathering performance data and assessing product refinements, scale-up needs and further commercial possibilities¹.

Trinity Biotech CEO John Gillard said, signing this contract now with RTI is an important step in moving Trinovium toward real-world commercial validation in this rapidly developing and innovating space, and that RTI's cooling fluid experience and commitment to become a commercial pilot customer gives the company a clear pathway to evaluate its cooling fluids and analytical systems in a U.S. data center environment, advancing the platform toward broader commercialization.¹

Trinity Biotech also cited third-party research projecting the data center liquid cooling market to grow from approximately $4 billion in 2026 to $27 billion by 2033¹. The company describes itself as a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors¹, and says through its Trinovium subsidiary, Trinity Biotech is extending its fluid manufacturing and analytical capabilities into advanced liquid cooling solutions for AI data center infrastructure¹.